Login
$ELDN
$2.01 +$0.04 (2.23%) After hours

$ELDN 8-K/A SEC Filings

Filed On Filing
14 Apr 2025 8-K/A: Changes in Registrant's Certifying Accountant

(a) Dismissal of Independent Registered Public Accounting Firm.

20 Nov 2020 8-K/A: Financial Statements and Exhibits

We consent to the incorporation by reference in the following Registration Statements:

20 Feb 2020 8-K/A: Unregistered Sales of Equity Securities; Amendments to Articles/Bylaws; Change in Fiscal Year

On February 13, 2020, Novus Therapeutics, Inc. (the “Company”) entered into an exchange agreement (the “Exchange Agreement”) with Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, ...

25 Jul 2017 8-K/A: Financial Statements and Exhibits

On December 21, 2016, Tokai Pharmaceuticals, Inc. (“Tokai”), a Delaware corporation, Otic Pharma, and the shareholders of Otic Pharma (each a “Seller” and collectively, the “Sellers”), entered into a Share Purchase Agreement (the “Share ...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support